Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
17.06
-0.54 (-3.07%)
At close: Mar 19, 2026
SHA:688553 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 2,328 | 1,782 | 1,206 | 1,306 |
Trading Asset Securities | - | 688.59 | 789.05 | 1,376 | 1,662 |
Cash & Short-Term Investments | 2,609 | 3,017 | 2,572 | 2,582 | 2,968 |
Cash Growth | -13.53% | 17.32% | -0.40% | -13.01% | 395.07% |
Accounts Receivable | - | 55.55 | 55.95 | 42.83 | 11.87 |
Other Receivables | - | 86.09 | 69.37 | 44.64 | 29.24 |
Receivables | - | 141.64 | 125.31 | 87.48 | 41.11 |
Inventory | - | 159.92 | 153.12 | 165.98 | 178.87 |
Prepaid Expenses | - | 0 | - | - | - |
Other Current Assets | - | 25.95 | 20.19 | 38 | 45.44 |
Total Current Assets | - | 3,344 | 2,870 | 2,873 | 3,233 |
Property, Plant & Equipment | - | 1,516 | 1,410 | 1,123 | 672.48 |
Long-Term Investments | - | 89.66 | 155.4 | 99.31 | 54.3 |
Other Intangible Assets | - | 60.57 | 62.09 | 63.51 | 64.01 |
Long-Term Deferred Tax Assets | - | 24.47 | 53.81 | 29.63 | 10.55 |
Long-Term Deferred Charges | - | 26.78 | 17.96 | 1.61 | - |
Other Long-Term Assets | - | 103.32 | 115.78 | 85.94 | 94.71 |
Total Assets | - | 5,166 | 4,686 | 4,277 | 4,130 |
Accounts Payable | - | 197.03 | 133.89 | 95.52 | 59.25 |
Accrued Expenses | - | 235.4 | 215.31 | 47.87 | 289.79 |
Short-Term Debt | - | 589.08 | 426.73 | 45.04 | 13.66 |
Current Portion of Leases | - | 1.64 | 2.85 | 5.43 | 3.06 |
Current Income Taxes Payable | - | 0.24 | 11.98 | 1.27 | 10.62 |
Current Unearned Revenue | - | 54.33 | 27.03 | 36.87 | 35.65 |
Other Current Liabilities | - | 59.03 | 61.52 | 294.39 | 80.88 |
Total Current Liabilities | - | 1,137 | 879.32 | 526.39 | 492.91 |
Long-Term Leases | - | - | 2.05 | 4.62 | 3.28 |
Long-Term Unearned Revenue | - | 48.98 | 24.3 | 22.15 | 24.21 |
Long-Term Deferred Tax Liabilities | - | 6.52 | 5.54 | 5.27 | 0.6 |
Other Long-Term Liabilities | - | - | - | - | 50.02 |
Total Liabilities | - | 1,192 | 911.22 | 558.44 | 571.01 |
Common Stock | - | 423.6 | 423.6 | 423.6 | 423.6 |
Additional Paid-In Capital | - | 2,487 | 2,485 | 2,474 | 2,473 |
Retained Earnings | - | 1,106 | 870.83 | 830.55 | 670.94 |
Treasury Stock | - | -30.02 | - | - | - |
Comprehensive Income & Other | - | -8.24 | -9.15 | -9.63 | -9.41 |
Total Common Equity | 3,731 | 3,979 | 3,771 | 3,718 | 3,558 |
Minority Interest | - | -5.66 | 3.83 | - | - |
Shareholders' Equity | 3,721 | 3,973 | 3,774 | 3,718 | 3,558 |
Total Liabilities & Equity | - | 5,166 | 4,686 | 4,277 | 4,130 |
Total Debt | 500.41 | 590.72 | 431.63 | 55.09 | 20 |
Net Cash (Debt) | 2,108 | 2,426 | 2,140 | 2,527 | 2,948 |
Net Cash Growth | -13.10% | 13.38% | -15.31% | -14.29% | 391.73% |
Net Cash Per Share | 5.23 | 5.74 | 5.05 | 5.99 | 7.93 |
Filing Date Shares Outstanding | 343.23 | 421.46 | 423.6 | 423.6 | 423.6 |
Total Common Shares Outstanding | 421.46 | 421.46 | 423.6 | 423.6 | 423.6 |
Working Capital | - | 2,208 | 1,991 | 2,347 | 2,741 |
Book Value Per Share | 8.85 | 9.44 | 8.90 | 8.78 | 8.40 |
Tangible Book Value | 3,671 | 3,918 | 3,709 | 3,655 | 3,494 |
Tangible Book Value Per Share | 8.71 | 9.30 | 8.75 | 8.63 | 8.25 |
Buildings | - | 654.99 | 315.19 | 179.43 | 127.91 |
Machinery | - | 648.03 | 574.16 | 436.3 | 323.89 |
Construction In Progress | - | 528.71 | 768.43 | 695.81 | 365.65 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.